Clinical Trials on Multiple Sclerosis in Denmark
Total 282 results
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveDenmark
-
Anna TsakiriSanofiWithdrawnRelapsing Remitting Multiple SclerosisDenmark
-
BiogenCompleted
-
Rigshospitalet, DenmarkCompletedProgressive Multiple SclerosisDenmark
-
Rigshospitalet, DenmarkDanish Research Centre for Magnetic ResonanceUnknownMultiple Sclerosis (Primary or Secondary Progressive Phase).Denmark
-
University of AarhusAarhus University Hospital; Regionshospitalet Viborg, Skive; Gødstrup Hospital; Sorbonne UniversityRecruitingRelapsing Remitting Multiple SclerosisDenmark
-
Rigshospitalet, DenmarkBiogenCompletedPrimary Progressive Multiple SclerosisDenmark
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterRecruitingPrimary Progressive Multiple SclerosisDenmark
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Statens Serum Institut; Copenhagen University Hospital... and other collaboratorsCompletedRelapsing Multiple SclerosisDenmark
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-RemittingDenmark
-
University of AarhusAarhus University Hospital; BiogenCompletedMultiple Sclerosis (Relapsing Remitting)Denmark
-
BayerWithdrawnMultiple SclerosisSweden, Denmark
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
University of AarhusOxford Brookes UniversityRecruiting
-
University of AarhusVIA University College; TrygFonden, Denmark; Fondazione Don Carlo Gnocchi OnlusCompleted
-
University of Southern DenmarkRecruitingMultiple SclerosisDenmark
-
University of AarhusUniversity of Southern Denmark; Region of Southern DenmarkCompleted
-
University of CopenhagenDanish Multiple Sclerosis SocietyUnknownMultiple SclerosisDenmark
-
University of AarhusSonderborg Hospital; The Danish Multiple Sclerosis SocietyCompleted
-
University of AarhusThe Danish Multiple Sclerosis SocietyCompletedMultiple Sclerosis | FatigueDenmark
-
Rigshospitalet, DenmarkUniversity of CopenhagenRecruiting
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
University of AarhusThe Danish MS SocietyCompleted
-
University of Southern DenmarkOdense University Hospital; Fonden til Lægevidenskabens Fremme; Sygehus Lillebaelt and other collaboratorsCompletedMultiple SclerosisDenmark
-
Odense University HospitalCompleted
-
University of AarhusThe Danish MS SocietyRecruitingMultiple SclerosisDenmark
-
Glostrup University Hospital, CopenhagenGenzyme, a Sanofi CompanyUnknown
-
University of Southern DenmarkBiogen; Region of Southern DenmarkCompleted
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing Forms of Multiple SclerosisSpain, Canada, France, Switzerland, Italy, Portugal, Denmark, Poland, Germany, United Kingdom
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
University of AarhusUniversity of Copenhagen; University of Southern DenmarkRecruitingMultiple Sclerosis | Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Aging | Healthy AgingDenmark
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
University of AarhusUniversity of Southern Denmark; Jascha fund; Knud and Edith Eriksens memorial... and other collaboratorsCompletedMultiple Sclerosis | Cognitive Impairment | Brain AtrophyDenmark
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
University of AarhusAarhus University Hospital; Biogen; MS-Clinic of Southern Jutland; MS-Clinic Viborg and other collaboratorsCompleted
-
University of Southern DenmarkBiogen; Region of Southern DenmarkCompletedMultiple SclerosisDenmark
-
University of AarhusCompleted
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
University of AarhusGenzyme, a Sanofi CompanyCompletedMultiple SclerosisDenmark
-
University of AarhusAarhus University Hospital; Danish MS Hospitals, Haslev and Ry; The Danish MS...Completed
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more